Intrahepatic cholestasis induced by α-naphthylisothiocyanate can cause gut-liver axis disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrahepatic cholestasis induced by α-naphthylisothiocyanate can cause gut-liver axis disorders
Authors
Keywords
Gut-liver axis, Alpha naphthylisothiocyanate, Cholestasis
Journal
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
Volume 86, Issue -, Pages 103672
Publisher
Elsevier BV
Online
2021-05-12
DOI
10.1016/j.etap.2021.103672
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
- (2020) Sidhartha R. Sinha et al. Cell Host & Microbe
- Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
- (2019) Benjamin H Mullish et al. GUT
- Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
- (2019) Weihua Chen et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- FXR Regulates Intestinal Cancer Stem Cell Proliferation
- (2019) Ting Fu et al. CELL
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Animal models of biliary injury and altered bile acid metabolism
- (2018) Valeria Mariotti et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
- (2018) Claudia Burrello et al. Nature Communications
- Attenuation of alpha-naphthylisothiocyanate (ANIT)-induced biliary fibrosis by depletion of hepatic macrophages in rats
- (2017) Hossain M. Golbar et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Slowly progressive cholangiofibrosis induced in rats by α-naphthylisothiocyanate (ANIT), with particular references to characteristics of macrophages and myofibroblasts
- (2013) Hossain M. Golbar et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 −/− mice
- (2012) Suzanne Devkota et al. NATURE
- Effect of alpha-naphthylisothiocyanate-induced liver injury on intestinal adaptation in a rat model of short bowel syndrome
- (2011) Igor Sukhotnik et al. PEDIATRIC SURGERY INTERNATIONAL
- Early Growth Response Factor-1 Limits Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice
- (2011) Bradley P. Sullivan et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now